Safety Warning: Lack of Human Trial Data for Stacking Combinations
The speaker explicitly warns that none of the proposed stacking combinations (GLP-1 with AOD, SLUPP332, MOTS-c, or 0304) have been tested together in human trials. Therefore, determining which layers belong in a plan and their order is a clinical decision requiring medical supervision rather than following generic 'stack lists.'
0304: Oral AMPK Activator for Energy Sensing
Compound 0304 is an oral peptide that activates AMPK, the cellular sensor for low energy. It acts as an accelerator to signal cells to produce more energy but is not a repair tool. The speaker notes it works on a different primary mechanism than Mounjaro (Tirzepatide).